Altarescu G - Search Results

1

Cutaneous silent periods in patients with Fabry disease.

Syed NA, Sandbrink F, Luciano CA, Altarescu G, Weibel T, Schiffmann R, Floeter MK. Syed NA, et al. Among authors: altarescu g. Muscle Nerve. 2000 Aug;23(8):1179-86. doi: 10.1002/1097-4598(200008)23:8<1179::aid-mus4>3.0.co;2-7. Muscle Nerve. 2000. PMID: 10918253

2

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.

Moore DF, Altarescu G, Ling GS, Jeffries N, Frei KP, Weibel T, Charria-Ortiz G, Ferri R, Arai AE, Brady RO, Schiffmann R. Moore DF, et al. Among authors: altarescu g. Stroke. 2002 Feb;33(2):525-31. doi: 10.1161/hs0202.102601. Stroke. 2002. PMID: 11823664 Clinical Trial.

3

Arterial wall properties and Womersley flow in Fabry disease.

Moore DF, Altarescu G, Pursley R, Campia U, Panza JA, Dimitriadis E, Schiffmann R. Moore DF, et al. Among authors: altarescu g. BMC Cardiovasc Disord. 2002;2:1. doi: 10.1186/1471-2261-2-1. Epub 2002 Jan 10. BMC Cardiovasc Disord. 2002. PMID: 11888483 Free PMC article.

4

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease.

Moore DF, Altarescu G, Herscovitch P, Schiffmann R. Moore DF, et al. Among authors: altarescu g. BMC Neurol. 2002 Jun 18;2:4. doi: 10.1186/1471-2377-2-4. BMC Neurol. 2002. PMID: 12079501 Free PMC article. Clinical Trial.

5

Profile of endothelial and leukocyte activation in Fabry patients.

DeGraba T, Azhar S, Dignat-George F, Brown E, Boutière B, Altarescu G, McCarron R, Schiffmann R. DeGraba T, et al. Among authors: altarescu g. Ann Neurol. 2000 Feb;47(2):229-33. Ann Neurol. 2000. PMID: 10665494

6

Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease.

Altarescu GM, Goldfarb LG, Park KY, Kaneski C, Jeffries N, Litvak S, Nagle JW, Schiffmann R. Altarescu GM, et al. Clin Genet. 2001 Jul;60(1):46-51. doi: 10.1034/j.1399-0004.2001.600107.x. Clin Genet. 2001. PMID: 11531969

7

White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions.

Moore DF, Altarescu G, Barker WC, Patronas NJ, Herscovitch P, Schiffmann R. Moore DF, et al. Among authors: altarescu g. Brain Res Bull. 2003 Dec 30;62(3):231-40. doi: 10.1016/j.brainresbull.2003.09.021. Brain Res Bull. 2003. PMID: 14698356

8

Enhanced endothelium-dependent vasodilation in Fabry disease.

Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, Panza JA, Schiffmann R. Altarescu G, et al. Stroke. 2001 Jul;32(7):1559-62. doi: 10.1161/01.str.32.7.1559. Stroke. 2001. PMID: 11441201 Free PMC article.

9

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy.

Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, Pease-Fye M, Ferri R, Brady RO, Herscovitch P, Schiffmann R. Moore DF, et al. Among authors: altarescu g. Circulation. 2001 Sep 25;104(13):1506-12. doi: 10.1161/hc3801.096352. Circulation. 2001. PMID: 11571244 Clinical Trial.

10

Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.

Garvey MA, Toro C, Goldstein S, Altarescu G, Wiggs EA, Hallett M, Schiffmann R. Garvey MA, et al. Among authors: altarescu g. Neurology. 2001 Feb 13;56(3):391-4. doi: 10.1212/wnl.56.3.391. Neurology. 2001. PMID: 11171908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters